United States · FDA National Drug Code directory
BioThrax
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 64678-211_548ed5a0-4263-4c30-997d-24db0c078ddf
- Product NDC
- 64678-211
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- Anthrax Vaccine Adsorbed
- Labeler
- Emergent BioDefense Operations Lansing, LLC
- Marketing category
- BLA
- Marketing start / end (source format)
- 19701104
- Source listing expiry
- 20271231
Source-listed ingredients
- BACILLUS ANTHRACIS STRAIN V770-NP1-R ANTIGENS — 100 ug/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, MULTI-DOSE in 1 CARTON (64678-211-01) / 5 mL in 1 VIAL, MULTI-DOSE (64678-211-05) · 64678-211-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →